Summary
AstraZeneca, a global biopharmaceutical leader, places high value on leveraging data to drive better healthcare outcomes. Within their Oncology division, understanding product performance is critical not just for internal strategy, but also for shaping the broader impact on patient care.
Recognizing the limitations of generic reporting tools, AstraZeneca partnered with Pharaoh Soft to design a custom QlikView application tailored specifically for visualizing Oncology product performance. The solution unified multiple data sources into a cohesive, scalable reporting platform, thus providing AstraZeneca’s teams with deeper, more actionable insights to support key business decisions.
The challenge
Fragmented Data and Limited Visibility in Tracking Oncology Product Performance
In an industry where product performance directly impacts lives, AstraZeneca’s Oncology division faced a familiar, yet pressing challenge: accessing clear, reliable, real-time insights across a wide range of pharmaceutical products.
Data was being collected from multiple sources ranging from internal sales systems to external market databases yet without a unified reporting mechanism, thus teams grappled with:
• Disparate data formats, requiring manual effort to consolidate and validate.
• Limited flexibility in existing BI tools, which couldn’t provide Oncology-specific KPIs or adapt quickly to new product lines.
• Slow, resource-heavy reporting cycles, delaying the ability to act on key trends or performance shifts.
The Oncology team requested a solution not only to address immediate reporting gaps but also to scale effortlessly as more products, markets, and datasets were introduced.
The Solution
Custom QlikView Application for Consolidated, Scalable Performance Reporting
Pharaoh Soft collaborated with AstraZeneca’s stakeholders to architect a reliable QlikView application, purpose-built for the Oncology division’s performance tracking needs.
Key solution highlights:
• Multi-Source Data Integration: Consolidated data from various systems and external feeds into a unified, reliable dashboard environment.
• Tailored Visualizations: Developed Oncology-specific metrics and custom visual elements, providing clarity on product performance across regions and timelines.
• Built-In Scalability: Designed the application architecture to accommodate the seamless addition of new products, datasets, or market inputs future-proofing AstraZeneca’s investment.
• User-Friendly Experience: Ensured leadership and analysts could access insights with minimal training, empowering faster decision-making.
The Result
Faster Reporting Cycles, Enhanced Visibility, and Scalable Growth Potential
Since implementing the custom QlikView solution, AstraZeneca’s Oncology division realized tangible benefits:
• Reduced reporting cycle times by over 45%, enabling leadership to access real-time performance insights without manual data consolidation.
• Improved data visibility and consistency, ensuring key stakeholders had a unified, trustworthy view of Oncology product metrics.
• Seamless scalability, allowing AstraZeneca to expand reporting coverage as new products and data sources were introduced, with no disruption.
• Enhanced ability to spot emerging trends and act swiftly giving AstraZeneca a competitive edge in strategic decision-making and market responsiveness.
By moving away from generic reporting tools and investing in a custom solution, AstraZeneca transformed data from scattered silos into a strategic asset paving the way for continued growth and impact in Oncology healthcare.
Looking for a reporting solution tailored to your exact business priorities? Let’s discuss how Pharaoh Soft can help you unlock deeper insights from your data.
Ready To Create A Solution Together?
We're Here To Partner With Your Organization On Your Next Project
